- S&P 5007,561.67−0.40%
- Nasdaq 10027,943.74−1.22%
- NVDA$162.85−2.01%
- AAPL$356.27+0.39%
- MSFT$523.88+0.17%
- GOOGL$295.77−0.98%
- AMZN$266.66−0.29%
- META$641.69+2.90%
- TSLA$390.22−1.82%
- AVGO$347.01−4.76%
- AMD$534.06−8.75%
- MU$778.31−2.52%
Stock news
317 stories
Investor guidesWhy Is AST SpaceMobile, Inc. (NASDAQ: ASTS) Stock Down 18% This Year?A failed launch, a pushed-back constellation target and heavy capital use reset the timetable even after six later satellites reached orbit. ASTS · OptimistFi Research Desk · 
Market narrative auditsRogers Corporation (NYSE: ROG) Targets $1.5 Billion in SalesManagement's 2030 sales and margin targets require a sharp break from the company's recent revenue decline. The first checkpoints arrive well before the deadline. ROG · OptimistFi Research Desk · 
Market narrative auditsEli Lilly and Company (NYSE: LLY) EloraTZP Adds Weight Loss and More DropoutsThe Phase 2 combination delivered 23.3% average weight loss at the top dose, but adverse-event dropouts reached 27% across treatment arms. LLY · OptimistFi Research Desk · 
Market narrative auditsMomentus Inc. (NASDAQ: MNTS) Completes NASA Satellite TestA $1.86 million flight demonstration worked in orbit. The harder test is turning technical proof into repeatable revenue without more heavy dilution. MNTS · OptimistFi Research Desk · 
Investment case changesCarMax, Inc. (NYSE: KMX) Made Lower Margins Pay in RetailRetail volume more than offset a smaller profit per car, but the same pricing trade did not improve wholesale profit. KMX · OptimistFi Research Desk · 
Market narrative auditsTesla, Inc. (NASDAQ: TSLA) Q3 Consensus Splits Cars and EnergyAnalysts expect vehicle deliveries to fall from the second quarter while energy-storage deployments rise. That is not an across-the-board rebound. TSLA · OptimistFi Research Desk · 
Investor guidesWhy Is Moderna, Inc. (NASDAQ: MRNA) Stock Up 569% This Year?A Phase 3 melanoma result turned oncology into a credible business line, but the rally still depends on data, approval and individualized manufacturing. MRNA · OptimistFi Research Desk · 
Market narrative auditsDividendology Explains VICI Properties Inc. (NYSE: VICI)'s 8% YieldDividendology separates rate pressure from tenant headlines. Filings show Caesars Entertainment, Inc. (NASDAQ: CZR) and MGM Resorts International (NYSE: MGM) supplied 71% of first-half contractual rent. VICI · OptimistFi Research Desk · 
Market narrative auditsFair Isaac Corporation (NYSE: FICO) Faces a 99-Cent Mortgage Score RivalTransUnion (NYSE: TRU) locked VantageScore mortgage pricing at $0.99 through 2028, putting a durable price gap beside the profit engine at Fair Isaac Corporation (NYSE: FICO). FICO · OptimistFi Research Desk · 
Market narrative auditsMicrosoft Corporation (NASDAQ: MSFT) Has a Cap on OpenAI Revenue SharingCNBC estimates OpenAI's annual run rate at $68 billion. Microsoft's revenue share is capped, and most Microsoft Cloud revenue comes from elsewhere. MSFT · OptimistFi Research Desk · 
Market narrative auditsLennar Corporation (NYSE: LEN) Cut Build Costs, but Margins LaggedConstruction costs fell, but land, pricing and selling pressure kept Lennar Corporation (NYSE: LEN) below the margin recovery implied by June guidance. LEN · OptimistFi Research Desk · 
Investment case changesSCYNEXIS, Inc. (NASDAQ: SCYX) Wins $18.5 Million for AntifungalBARDA can provide up to $214 million, but only $18.5 million is committed in the base period. SCYX · OptimistFi Research Desk ·
ASTS · OptimistFi Research Desk · 
LLY · OptimistFi Research Desk · 
MNTS · OptimistFi Research Desk · 
KMX · OptimistFi Research Desk · 
MRNA · OptimistFi Research Desk · 
VICI · OptimistFi Research Desk · 
FICO · OptimistFi Research Desk · 
LEN · OptimistFi Research Desk · 
SCYX · OptimistFi Research Desk ·